A large, long, event-driven trial that counts heart attacks, strokes and cardiovascular deaths rather than measuring weight or glucose. It answers whether a treatment changes what happens to patients, not just what happens to their markers. Thousands of participants and years of follow-up are needed because events are rare.
Such trials became an expectation for glucose-lowering agents after earlier safety concerns in other drug classes.
Several GLP-1 receptor agonists have completed outcome trials in people with type 2 diabetes, with reductions in major cardiovascular events for some agents. SELECT extended this to people with obesity without diabetes: 17,604 participants, a 20 per cent relative reduction in the composite endpoint over a mean follow-up of around 40 months.
These are results for specific molecules in specific populations, and they are the strongest evidence the class has.
No cardiovascular outcome trial has been published. The phase 2 trials measured blood pressure, lipids and heart rate as markers; they did not and could not count events. Whether retatrutide affects cardiovascular outcomes is unknown in the strict sense, and any statement otherwise is extrapolation from the class.
Retatrutide is supplied by REVIVE LAB UAE as an investigational research material for laboratory use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not approved for any use anywhere, and no dosing, administration or protocol guidance is provided.
| Format | Strength | Price | Availability |
|---|---|---|---|
| Retatrutide Pack | 20 mg | AED 1010 | In stock |
Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.
A large, long, event-driven trial that counts heart attacks, strokes and cardiovascular deaths rather than measuring weight or glucose. It answers whether a treatment changes what happens to patients, not just what happens to their markers. Thousands of participants and years of follow-up are needed because events are rare.
No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.
Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.
Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.